GR852622B - - Google Patents

Info

Publication number
GR852622B
GR852622B GR852622A GR850102622A GR852622B GR 852622 B GR852622 B GR 852622B GR 852622 A GR852622 A GR 852622A GR 850102622 A GR850102622 A GR 850102622A GR 852622 B GR852622 B GR 852622B
Authority
GR
Greece
Prior art keywords
residues
protein
linked glycoside
terminal
daltons
Prior art date
Application number
GR852622A
Other languages
English (en)
Inventor
Ingegerd Hellstrom
Joseph P Brown
Karl Erik Hellstrom
Diane Horn
Peter Linsley
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of GR852622B publication Critical patent/GR852622B/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023Lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864Monoclonal
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR852622A 1984-11-02 1985-10-31 GR852622B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66752184A 1984-11-02 1984-11-02
US78517785A 1985-10-07 1985-10-07

Publications (1)

Publication Number Publication Date
GR852622B true GR852622B (el) 1986-03-04

Family

ID=27099700

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852622A GR852622B (el) 1984-11-02 1985-10-31

Country Status (21)

Country Link
EP (2) EP0207090B1 (el)
JP (3) JPH0675514B2 (el)
KR (1) KR910000903B1 (el)
AT (1) ATE117089T1 (el)
AU (1) AU599578B2 (el)
DE (1) DE3587976T2 (el)
DK (1) DK170619B1 (el)
ES (1) ES8704735A1 (el)
FI (1) FI85814C (el)
GB (1) GB2182949B (el)
GR (1) GR852622B (el)
HU (1) HU208546B (el)
IE (1) IE58590B1 (el)
IL (1) IL76877A (el)
NO (1) NO862690D0 (el)
NZ (1) NZ214055A (el)
OA (1) OA08354A (el)
PH (1) PH24961A (el)
PT (1) PT81418B (el)
WO (1) WO1986002735A1 (el)
YU (1) YU46386B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708930A (en) * 1984-11-09 1987-11-24 Coulter Corporation Monoclonal antibody to a human carcinoma tumor associated antigen
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas
US5185432A (en) * 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas
JPS6319561A (ja) * 1986-07-11 1988-01-27 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺癌単クロ−ン性抗体
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
IL89102A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Vectors,compounds and methods for expression of a human adenocarcinoma antigen
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
IT1254309B (it) * 1992-02-17 1995-09-14 Uni Degli Studi G D Annunzio C Sequenze genetiche per l'antigene 90k associato a tumori.
IT1264490B (it) * 1992-02-17 1996-09-24 Uni Degli Studi G D Annunzio C Antigene 90k associato a tumori.
JPH0727604U (ja) * 1993-06-18 1995-05-23 修司 坂本 磁気治療具
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
DE202012001863U1 (de) 2012-02-22 2012-03-19 Haldex Brake Products Ab Scheibenbremse und Sensoreinrichtung hierfür

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4906562A (en) * 1984-12-21 1990-03-06 Oncogen Monocolonal antibodies and antigen for human non-small cell lung carcinomas
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
AU601680B2 (en) * 1985-05-28 1990-09-20 Joseph P. Brown Monoclonal antibodies for human non-small cell lung carcinomas

Also Published As

Publication number Publication date
ATE117089T1 (de) 1995-01-15
ES8704735A1 (es) 1987-04-16
YU172185A (en) 1989-08-31
IE58590B1 (en) 1993-10-20
KR910000903B1 (ko) 1991-02-12
NZ214055A (en) 1991-06-25
JPS62501955A (ja) 1987-08-06
AU599578B2 (en) 1990-07-26
FI85814B (fi) 1992-02-28
DK314586A (da) 1986-09-01
DK170619B1 (da) 1995-11-13
JPH0733400B2 (ja) 1995-04-12
DE3587976D1 (de) 1995-02-23
FI862821A (fi) 1986-07-02
DE3587976T2 (de) 1995-05-18
FI85814C (fi) 1992-06-10
JPH0675514B2 (ja) 1994-09-28
PT81418A (en) 1985-11-01
DK314586D0 (da) 1986-07-02
WO1986002735A1 (en) 1986-05-09
FI862821A0 (fi) 1986-07-02
EP0207090B1 (en) 1995-01-11
IL76877A (en) 1991-11-21
ES548421A0 (es) 1987-04-16
IE852681L (en) 1986-05-02
GB2182949B (en) 1989-05-24
JPH06296497A (ja) 1994-10-25
HUT43188A (en) 1987-09-28
PT81418B (pt) 1987-11-11
NO862690D0 (no) 1986-07-02
EP0207090A1 (en) 1987-01-07
EP0207090A4 (en) 1988-04-26
KR880700268A (ko) 1988-02-22
IL76877A0 (en) 1986-02-28
GB2182949A (en) 1987-05-28
AU5069185A (en) 1986-05-15
JP2567564B2 (ja) 1996-12-25
HU208546B (en) 1993-11-29
YU46386B (sh) 1993-10-20
OA08354A (en) 1988-02-29
JPH06340699A (ja) 1994-12-13
GB8616219D0 (en) 1986-08-13
EP0566066A1 (en) 1993-10-20
PH24961A (en) 1990-12-26

Similar Documents

Publication Publication Date Title
GR852622B (el)
ES2139764T3 (es) Analogos de eritropoyetina.
GR861141B (en) Particles having the immunogenic properties of the hbs antigen and an antigenic side strange to the epitopes of the antigen hbs vectors and animals cells for the production of said particles and compositions containing such particles
ES2007425A6 (es) Un metodo para la produccion de una proteina con actividad inhibidora del crecimiento de tumores.
KR880009991A (ko) 항혈액응고작용을 갖는 폴리펩티드
AUPM772494A0 (en) Improvements in production of proteins in host cells
ES8605296A1 (es) Procedimiento de producir factor viii-r humano